Drug reference
unfractionated heparin
Anticoagulant
Anticoagulant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
Anticoagulant therapy added to antiplatelet agents for NSTE-ACSPatients with STEMI undergoing primary PCIAdjunctive to aspirin and non-fibrin-specific thrombolytic agents (e.g., streptokinase)Maintenance of patency of infarct-related artery when used with aspirin and relatively fibrin-specific fibrinolytic agents (tPA, rPA, or TNK)Full therapeutic levels for patients with suspected mural thrombus (while hospitalized)VTEprophylaxis for VTE
Dosing
- Adult
- Bolus: 70–100 U/kg (maximum 5000 U) IV. Infusion: 12–15 U/kg per h titrated to ACT 250–300 s.
Related guidelines
Other Unclassified drugs
Ask House about unfractionated heparin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team